Abnormal NMDA-related Electrophysiology in Parkinson Disease Dementia
Objective: Investigate mismatch negativity in Parkinson disease with dementia. Background: Parkinson’s disease with dementia (PDD) is an important cause of cognitive impairment in Parkinson’s disease…Modulation of CaMKIIa-NR2B interaction in levodopa-induced dyskinesia in 6-OHDA- lesioned Parkinson’s rats
Objective: In the present study, therefore, we examined the relationship between CaMKII and NR2B in levodopa-induced dyskinesia rats. Background: Long-term treatment with L-dopa leads to…The movement disorder associated with NMDAR-antibody encephalitis: An expert-rater video study
Objective: To use movement disorder (MD) expert analysis of phenomenology to provide a comprehensive evaluation of the MD associated with NMDA receptor-antibody encephalitis (NMDAR-AbE). Background:…The spectrum of abnormal movements and predictors of outcome in anti-NMDA receptor encephalitis in Thai patients
Objective: To describe the spectrum of abnormal movements and predictor of outcome in Thai patients with anti-NMDA receptor (NMDAR) encephalitis. Background: Anti-NMDAR encephalitis mostly presented…Preclinical evaluation of sub-anesthetic ketamine infusion to reduce L-DOPA-induced dyskinesias: Is it a ‘chemical’ DBS?
Objective: To evaluate mechanism of long-term activity of sub-anesthetic ketamine infusion to reduce L-DOPA-induced dyskinesias (LID). Background: Ketamine is an anesthetic that, when administered as…Patient case reports supporting a long-term effect of sub-anesthetic ketamine infusion in reducing L-DOPA-induced dyskinesias
Objective: To evaluate possible long-term anti-dyskinetic activity of low-dose sub-anesthetic ketamine infusion from a retrospective chart review. Background: Repurposing drugs that have already been proven…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.